Article Information
- Received August 28, 2015
- Revision received April 7, 2016
- Accepted April 11, 2016
- Published online May 2, 2016.
Author Information
- Sinéad Kinsella,
- Hans-Georg König and
- Jochen H.M. Prehn
- Department of Physiology and Medical Physics, Centre for the Study of Neurological Disorders, Royal College of Surgeons in Ireland, 123 St. Stephen’s Green, Dublin 2, Ireland
- Correspondence should be addressed to Jochen H. M. Prehn, Department of Physiology and Medical Physics, Royal College of Surgeons in Ireland, 123 St. Stephen’s Green, Dublin 2, Ireland. E-mail: prehn{at}rcsi.ie.
Author contributions
↵2 Author contributions: S.K., H.-G.K., and J.H.M.P. designed research; S.K. performed research; S.K. and H.-G.K. analyzed data; S.K., H.-G.K., and J.H.M.P. wrote the paper.
Disclosures
↵1 The authors declare no conflict of interest.
↵3 This work was supported by the BioAnalysis and Therapeutics PhD scholars program under the Programme for Research in Third Level Institutions (PRTLI) Cycle 5 and funding from the Science Foundation Ireland (08/INV.1/B1949). The PRTLI is co-funded through the European Regional Development Fund, part of the European Union Structural Funds Programme 2007–2013. We thank Mathew King for the generation of the plasmids encoding the SOD1G93A-CFP fusion protein, Ina Woods and Shona Pfeiffer for proficient technical assistance in animal breeding, Caroline Jefferies for some valuable advice and for donating the Ubiquitin encoding plasmid, and Manuela Salvucci for assistance with statistical analyses.
Funding
This work is funded by the BioAnalysis and Therapeutics PhD scholars programme unde the Programme for Research in Third Level Institutes (PRTLI) Cycle 5. The PRTLI is funded under the European Regional Development Fund (ERDF), part of the European Union Structural Funds Programme 2007 - 2013.
PRTLI Cycle 5Science Foundation Ireland (SFI)
501100001602; 08/INV.1/B1949
Other Version
- You are viewing the most recent version of this article.
- previous version (May 02, 2016).
Online Impact